Donate

Blog Grid

02 Oct 2018

Berkeley Conference | Controlling the switch between environmental and virulence programs of Mycobacterium avium

Dr. Jonathan Budzik is a Visiting Scholar at the University of California Berkeley Cox Lab and an Assistant Professor in the Division of Pulmonary & Critical Care  at the University of California, San Francisco. His research interests include understanding the changes in host protein phosphorylation during M. tuberculosis infection and investigating the molecular basis for M. avium. complex virulence.

in 2018 Berkeley
Berkeley Conference | Introduction
30 Sep 2018

Berkeley Conference | Introduction

To kick off Human Para’s 2018 conference, Mycobacterial Implications in Crohn’s and Chronic Inflammatory Diseases, Dr. William Chamberlin provided a brief overview of the history of atypical mycobacteria in human disease, suggestions on how to change the status quo by establishing causality and discussed the challenges going forward.

in 2018 Berkeley
Berkeley Conference | A Call for Action
03 Sep 2018

Berkeley Conference | A Call for Action

Nontuberculous mycobacteria (NTM) are not only conventional opportunistic pathogens, but they are important sources of triggers of chronic immune-mediated and autoimmune disorders. In this short note and associated paper, Dr. Karel Hruska highlights the risk posed by NTM in water, food, and soil. Hence NTM are associated with the so called “civilization diseases” (Type 1 diabetes, Crohn’s disease, multiple sclerosis, asthma, psoriasis, rheumatoid arthritis, and others.)

in 2018 Berkeley, News
Cardiac Sarcoidosis Patient Healed by Anti-MAP Antibiotics
26 Aug 2018

Cardiac Sarcoidosis Patient Healed by Anti-MAP Antibiotics

The author of this recent case study, Branko G. Celler, an Emeritus Professor at the University of New South Wales in Sydney, Australia, developed a particularly serious form of sarcoidosis in 2012. While sarcoidosis is a chronic disease characterized by the formation of granulomas in various organs, only a small portion of patients have cardiac involvement, which can lead to symptomatic conduction disturbances, ventricular arrhythmias, progressive heart failure and sudden death. Read more about his recovery with anti-mycobacterial antibiotics.

in News